Chargement en cours...
Overcoming resistance to immunotherapy by teaching old drugs new tricks
Cancer stem cells (CSCs) underlie resistance to therapy. Cancer develops only in the context of failing immunosurveillance, and stem cells occupy immune privileged microenvironments. Recent evidence demonstrates that CSCs borrow immune privilege from their normal counterparts. However, low doses of...
Enregistré dans:
| Publié dans: | Mol Cell Oncol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7469442/ https://ncbi.nlm.nih.gov/pubmed/32944648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2020.1801088 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|